Abstract
Suramin is the drug of choice for the treatment of African trypanosomiasis and onchocerciasis. It is also tested for its potential use as an anticancer agent and chemosensitizer. As suramin has been reported to induce hyperglycaemia, its effect on glucose formation has been studied in isolated rabbit hepatocytes and kidney-cortex tubules. In contrast to hepatocytes, in kidney-cortex tubules suramin augments glucose production and decreases lactate formation. Suramin-induced changes in intracellular gluconeogenic/glycolytic intermediates indicate a decrease in flux through pyruvate-phosphoenolpyruvate step. Moreover, this compound diminishes pyruvate kinase activity in kidney-cortex cytosolic fraction, while fructose-1,6-bisphosphate ameliorates its inhibitory action. As (i) kidneys are important contributors to the whole body glucose homeostasis and (ii) suramin is known to accumulate in kidney, suramin-induced stimulation of glucose formation in renal tubules might be responsible for hyperglycaemia observed in patients undergoing suramin treatment.
References
Mar 15, 1978·Biochemical and Biophysical Research Communications·S J PilkisT H Claus
Nov 15, 1978·The Biochemical Journal·J Zaleski, J Bryła
Jan 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S OlivierG Milano
Aug 15, 1990·Journal of the National Cancer Institute·M Pollak, M Richard
Feb 1, 1988·British Journal of Pharmacology·P M Dunn, A G Blakeley
Apr 15, 1988·The Biochemical Journal·L HueM H Rider
Jan 1, 1985·Journal of Cellular Biochemistry·M Hosang
Feb 1, 1973·The Biochemical Journal·M G Irving, J F Williams
Feb 1, 1970·Biochemical Medicine·M S Usatenko
Oct 12, 1984·Science·H MitsuyaS Broder
May 4, 1983·Biochimica Et Biophysica Acta·K ZabłockiJ Bryła
Aug 20, 1995·Archives of Biochemistry and Biophysics·T Lietz, J Bryła
Mar 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·S BaghdiguianJ Fantini
Mar 17, 1999·Amino Acids·T LietzJ Bryła
Aug 10, 1999·Drugs·G Gasparini
Oct 24, 2000·Life Sciences·W P McNallyL R Whitfield
Feb 24, 2001·Diabetes Care·J E GerichM Stumvoll
Feb 28, 2002·Current Pharmaceutical Design·Richard J S BurchmoreMichael P Barrett
Dec 1, 1958·Archives of Biochemistry and Biophysics·A TIETZ, S OCHOA
Dec 14, 2004·Pharmaceutical Research·Adam OgdenJessie L S Au
Jun 11, 2005·The Journal of Urology·Yan XinJessie L-S Au